n-Lorem Foundation Revenue and Competitors
Estimated Revenue & Valuation
- n-Lorem Foundation's estimated annual revenue is currently $4.8M per year.
- n-Lorem Foundation's estimated revenue per employee is $140,000
Employee Data
- n-Lorem Foundation has 34 Employees.
- n-Lorem Foundation grew their employee count by 31% last year.
n-Lorem Foundation's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Chief Technical Officer | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Operating Officer | Reveal Email/Phone |
6 | VP, ASO Discovery and Development | Reveal Email/Phone |
7 | Associate Director, CMC Drug Substance and Drug Product | Reveal Email/Phone |
8 | Assistant Director Research | Reveal Email/Phone |
9 | Executive Director, Finance | Reveal Email/Phone |
10 | Executive Director Communications and Donor Relations | Reveal Email/Phone |
n-Lorem Foundation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 198 | 1% | $6.3M | N/A |
#2 | $3.9M | 28 | -12% | N/A | N/A |
#3 | $35M | 233 | 24% | N/A | N/A |
#4 | $7.5M | 10 | -47% | N/A | N/A |
#5 | $4.5M | 32 | 10% | N/A | N/A |
#6 | $1.7M | 73 | 18% | N/A | N/A |
#7 | $7.5M | 88 | 5% | N/A | N/A |
#8 | $15M | 57 | 14% | N/A | N/A |
#9 | $9.2M | 66 | 65% | N/A | N/A |
#10 | $15M | 232 | 19% | N/A | N/A |
What Is n-Lorem Foundation?
n-Lorem’s mission is to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotides (ASO) medicines to treat patients with nano-rare diseases.
keywords:N/AN/A
Total Funding
34
Number of Employees
$4.8M
Revenue (est)
31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.4M | 34 | 31% | N/A |
#2 | $8.5M | 34 | 31% | N/A |
#3 | $7.9M | 34 | -15% | N/A |
#4 | $3.9M | 34 | N/A | N/A |
#5 | $5.4M | 35 | 3% | N/A |